| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| Gesamt | 6.055.643 $ | 70,60 | 319.425 | ||||||
| CRINETICS PHARMACEUTICALS INC | Crinetics Pharmaceuticals, Inc. | EC | 22663K107 | Long | Börsenkurs (Stufe 1) | 223.416 $ | 2,60 | 2.675 | |
| MBX BIOSCIENCES INC | MBX Biosciences, Inc. | EC | 55287L101 | Long | Börsenkurs (Stufe 1) | 195.351 $ | 2,28 | 2.963 | |
| ATAIBECKLEY INC | AtaiBeckley, Inc. | EC | 04650F101 | Long | Börsenkurs (Stufe 1) | 174.388 $ | 2,03 | 24.288 | |
| DEFINIUM THERAPEUTICS INC | Definium Therapeutics, Inc. | EC | 24477V105 | Long | Börsenkurs (Stufe 1) | 171.904 $ | 2,00 | 3.950 | |
| AMYLYX PHARMACEUTICALS INC | Amylyx Pharmaceuticals, Inc. | EC | 03237H101 | Long | Börsenkurs (Stufe 1) | 138.535 $ | 1,62 | 6.821 | |
| ENLIVEN THERAPEUTICS INC | Enliven Therapeutics, Inc. | EC | 29337E102 | Long | Börsenkurs (Stufe 1) | 135.984 $ | 1,59 | 2.481 | |
| CORCEPT THERAPEUTICS INC | Corcept Therapeutics, Inc. | EC | 218352102 | Long | Börsenkurs (Stufe 1) | 134.526 $ | 1,57 | 1.175 | |
| ALUMIS INC | Alumis, Inc. | EC | 022307102 | Long | Börsenkurs (Stufe 1) | 129.300 $ | 1,51 | 4.577 | |
| NUVATION BIO INC | Nuvation Bio, Inc. | EC | 67080N101 | Long | Börsenkurs (Stufe 1) | 126.885 $ | 1,48 | 20.045 | |
| TREVI THERAPEUTICS INC | Trevi Therapeutics, Inc. | EC | 89532M101 | Long | Börsenkurs (Stufe 1) | 125.031 $ | 1,46 | 6.851 | |
| LIQUIDIA CORP | Liquidia Corporation | EC | 53635D202 | Long | Börsenkurs (Stufe 1) | 118.343 $ | 1,38 | 1.407 | |
| NEKTAR THERAPEUTICS | Nektar Therapeutics | EC | 640268306 | Long | Börsenkurs (Stufe 1) | 114.273 $ | 1,33 | 1.617 | |
| AMNEAL PHARMACEUTICALS INC | Amneal Pharmaceuticals, Inc. | EC | 03168L105 | Long | Börsenkurs (Stufe 1) | 109.792 $ | 1,28 | 5.993 | |
| BRISTOL-MYERS SQUIBB COMPANY | Bristol-Myers Squibb Company | EC | 110122108 | Long | Börsenkurs (Stufe 1) | 107.827 $ | 1,26 | 1.651 | |
| EDGEWISE THERAPEUTICS INC | Edgewise Therapeutics, Inc. | EC | 28036F105 | Long | Börsenkurs (Stufe 1) | 107.181 $ | 1,25 | 2.789 | |
| OMEROS CORP | Omeros Corporation | EC | 682143102 | Long | Börsenkurs (Stufe 1) | 106.572 $ | 1,24 | 9.001 | |
| LIGAND PHARMACEUTICALS INC | Ligand Pharmaceuticals, Inc. | EC | 53220K504 | Long | Börsenkurs (Stufe 1) | 106.390 $ | 1,24 | 370 | |
| ELANCO ANIMAL HEALTH INC | Elanco Animal Health, Inc. | EC | 28414H103 | Long | Börsenkurs (Stufe 1) | 105.849 $ | 1,23 | 4.014 | |
| VERADERMICS INC | VeraDermics, Inc. | EC | 922967104 | Long | Börsenkurs (Stufe 1) | 103.635 $ | 1,21 | 987 | |
| PACIRA BIOSCIENCES INC | Pacira BioSciences, Inc. | EC | 695127100 | Long | Börsenkurs (Stufe 1) | 103.527 $ | 1,21 | 3.920 | |
| VIATRIS INC | Viatris, Inc. | EC | 92556V106 | Long | Börsenkurs (Stufe 1) | 102.234 $ | 1,19 | 5.822 | |
| JAZZ PHARMACEUTICALS PLC | Jazz Pharmaceuticals plc | EC | G50871105 | Long | Börsenkurs (Stufe 1) | 101.144 $ | 1,18 | 400 | |
| ETON PHARMACEUTICALS INC | Eton Pharmaceuticals, Inc. | EC | 29772L108 | Long | Börsenkurs (Stufe 1) | 100.685 $ | 1,17 | 2.169 | |
| MAZE THERAPEUTICS INC | Maze Therapeutics, Inc. | EC | 578784100 | Long | Börsenkurs (Stufe 1) | 100.492 $ | 1,17 | 3.733 | |
| MERCK & COMPANY INC | Merck & Company, Inc. | EC | 58933Y105 | Long | Börsenkurs (Stufe 1) | 100.384 $ | 1,17 | 771 | |
| HARROW INC | Harrow, Inc. | EC | 415858109 | Long | Börsenkurs (Stufe 1) | 99.135 $ | 1,16 | 2.557 | |
| JOHNSON & JOHNSON | Johnson & Johnson | EC | 478160104 | Long | Börsenkurs (Stufe 1) | 98.695 $ | 1,15 | 385 | |
| ROYALTY PHARMA PLC | Royalty Pharma plc | EC | G7709Q104 | Long | Börsenkurs (Stufe 1) | 98.396 $ | 1,15 | 1.684 | |
| INDIVIOR PHARMACEUTICALS INC | Indivior Pharmaceuticals, Inc. | EC | 45579U109 | Long | Börsenkurs (Stufe 1) | 96.424 $ | 1,12 | 2.410 | |
| PRESTIGE CONSUMER HEALTHCARE INC | Prestige Consumer Healthcare, Inc. | EC | 74112D101 | Long | Börsenkurs (Stufe 1) | 93.861 $ | 1,09 | 1.869 | |
| COLLEGIUM PHARMACEUTICAL INC | Collegium Pharmaceutical, Inc. | EC | 19459J104 | Long | Börsenkurs (Stufe 1) | 93.359 $ | 1,09 | 2.638 | |
| ELI LILLY & COMPANY | Eli Lilly & Company | EC | 532457108 | Long | Börsenkurs (Stufe 1) | 93.056 $ | 1,08 | 81 | |
| ORGANON & COMPANY | Organon & Company | EC | 68622V106 | Long | Börsenkurs (Stufe 1) | 92.980 $ | 1,08 | 6.862 | |
| EYEPOINT INC | EyePoint Pharmaceuticals, Inc. | EC | 30233G209 | Long | Börsenkurs (Stufe 1) | 91.214 $ | 1,06 | 7.446 | |
| HARMONY BIOSCIENCES HOLDINGS INC | Harmony Biosciences Holdings, Inc. | EC | 413197104 | Long | Börsenkurs (Stufe 1) | 91.201 $ | 1,06 | 2.588 | |
| SUPERNUS PHARMACEUTICALS INC | Supernus Pharmaceuticals, Inc. | EC | 868459108 | Long | Börsenkurs (Stufe 1) | 90.867 $ | 1,06 | 2.036 | |
| PFIZER INC | Pfizer, Inc. | EC | 717081103 | Long | Börsenkurs (Stufe 1) | 89.686 $ | 1,05 | 3.586 | |
| WAVE LIFE SCIENCES LTD | WaVe Life Sciences Ltd. | EC | Y95308105 | Long | Börsenkurs (Stufe 1) | 89.378 $ | 1,04 | 16.221 | |
| PHIBRO ANIMAL HEALTH CORP | Phibro Animal Health Corporation | EC | 71742Q106 | Long | Börsenkurs (Stufe 1) | 89.372 $ | 1,04 | 2.460 | |
| ANI PHARMACEUTICALS INC | ANI Pharmaceuticals, Inc. | EC | 00182C103 | Long | Börsenkurs (Stufe 1) | 88.907 $ | 1,04 | 1.122 | |
| TARSUS PHARMACEUTICALS INC | Tarsus Pharmaceuticals, Inc. | EC | 87650L103 | Long | Börsenkurs (Stufe 1) | 88.442 $ | 1,03 | 1.498 | |
| ZOETIS INC | Zoetis, Inc. | EC | 98978V103 | Long | Börsenkurs (Stufe 1) | 87.260 $ | 1,02 | 1.129 | |
| OCULAR THERAPEUTIX INC | Ocular Therapeutix, Inc. | EC | 67576A100 | Long | Börsenkurs (Stufe 1) | 85.818 $ | 1,00 | 10.504 | |
| XERIS BIOPHARMA HOLDINGS INC | Xeris Biopharma Holdings, Inc. | EC | 98422E103 | Long | Börsenkurs (Stufe 1) | 85.422 $ | 1,00 | 10.572 | |
| RAPPORT THERAPEUTICS INC | Rapport Therapeutics, Inc. | EC | 75383L102 | Long | Börsenkurs (Stufe 1) | 85.074 $ | 0,99 | 2.076 | |
| INNOVIVA INC | Innoviva, Inc. | EC | 45781M101 | Long | Börsenkurs (Stufe 1) | 83.712 $ | 0,98 | 3.992 | |
| PERRIGO COMPANY PLC | Perrigo Company plc | EC | G97822103 | Long | Börsenkurs (Stufe 1) | 83.094 $ | 0,97 | 8.219 | |
| AXSOME THERAPEUTICS INC | Axsome Therapeutics, Inc. | EC | 05464T104 | Long | Börsenkurs (Stufe 1) | 81.310 $ | 0,95 | 373 | |
| AMPHASTAR PHARMACEUTICALS INC | Amphastar Pharmaceuticals, Inc. | EC | 03209R103 | Long | Börsenkurs (Stufe 1) | 74.376 $ | 0,87 | 3.730 | |
| ARVINAS INC | Arvinas, Inc. | EC | 04335A105 | Long | Börsenkurs (Stufe 1) | 72.495 $ | 0,85 | 9.028 | |
| ALTO NEUROSCIENCE INC | Alto Neuroscience Inc | EC | 02157Q109 | Long | Börsenkurs (Stufe 1) | 72.304 $ | 0,84 | 2.671 | |
| SEPTERNA INC | Septerna, Inc. | EC | 81734D104 | Long | Börsenkurs (Stufe 1) | 61.287 $ | 0,71 | 1.779 | |
| LB PHARMACEUTICALS INC | LB Pharmaceuticals, Inc. | EC | 50180M108 | Long | Börsenkurs (Stufe 1) | 59.198 $ | 0,69 | 1.477 | |
| CORMEDIX INC | CorMedix, Inc. | EC | 21900C308 | Long | Börsenkurs (Stufe 1) | 58.139 $ | 0,68 | 7.721 | |
| THERAVANCE BIOPHARMA INC | Theravance Biopharma, Inc. | EC | G8807B106 | Long | Börsenkurs (Stufe 1) | 57.088 $ | 0,67 | 3.386 | |
| ACLARIS THERAPEUTICS INC | Aclaris Therapeutics, Inc. | EC | 00461U105 | Long | Börsenkurs (Stufe 1) | 52.863 $ | 0,62 | 10.166 | |
| PHATHOM PHARMACEUTICALS INC | Phathom Pharmaceuticals, Inc. | EC | 71722W107 | Long | Börsenkurs (Stufe 1) | 51.581 $ | 0,60 | 5.895 | |
| ZEVRA THERAPEUTICS INC | Zevra Therapeutics, Inc. | EC | 488445206 | Long | Börsenkurs (Stufe 1) | 49.328 $ | 0,58 | 5.187 | |
| RELMADA THERAPEUTICS INC | Relmada Therapeutics, Inc. | EC | 75955J402 | Long | Börsenkurs (Stufe 1) | 48.847 $ | 0,57 | 9.199 | |
| AQUESTIVE THERAPEUTICS INC | Aquestive Therapeutics, Inc. | EC | 03843E104 | Long | Börsenkurs (Stufe 1) | 40.870 $ | 0,48 | 11.061 | |
| FULCRUM THERAPEUTICS INC | Fulcrum Therapeutics, Inc. | EC | 359616109 | Long | Börsenkurs (Stufe 1) | 40.601 $ | 0,47 | 11.341 | |
| LEXICON PHARMACEUTICALS INC | Lexicon Pharmaceuticals Inc | EC | 528872302 | Long | Börsenkurs (Stufe 1) | 36.396 $ | 0,42 | 15.756 | |
| BIOAGE LABS INC | BioAge Labs, Inc. | EC | 09077V100 | Long | Börsenkurs (Stufe 1) | 33.276 $ | 0,39 | 3.681 | |
| EVOLUS INC | Evolus, Inc. | EC | 30052C107 | Long | Börsenkurs (Stufe 1) | 26.683 $ | 0,31 | 4.569 | |
| Gesamt | 6.055.643 $ | 70,60 | 319.425 |